Literature DB >> 6477229

Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.

L K Direnfeld, M L Albert, L Volicer, P J Langlais, J Marquis, E Kaplan.   

Abstract

We examined the relationship of disease laterality to neuropsychological and neurochemical features in patients with idiopathic Parkinson's disease (PD). We tested patients with PD, patients with Alzheimer's type of senile dementia, and a control group neuropsychologically, and we determined their CSF levels of homovanillic acid, 3,4-dihydroxyphenylacetic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindolacetic acid, serotonin, and acetylcholinesterase. The patients with PD were divided into two groups depending on the side of the body with greater disease involvement. Both parkinsonian groups, those more affected on the left (group L) and those more affected on the right (group R), were otherwise similar in all other clinical and historical features. Group L patients showed greater neuropsychological impairments than group R patients. Group L also had significantly higher CSF levels of homovanillic acid and acetylcholinesterase than group R. These findings of neuropsychological and neurochemical differences between groups L and R suggest functional or anatomic asymmetries of dopaminergic systems in the CNS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477229     DOI: 10.1001/archneur.1984.04050200041016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

Review 1.  Cognitive differences between patients with left-sided and right-sided Parkinson's disease. A review.

Authors:  Nele Verreyt; Gudrun M S Nys; Patrick Santens; Guy Vingerhoets
Journal:  Neuropsychol Rev       Date:  2011-09-29       Impact factor: 7.444

2.  Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease.

Authors:  Thomas Holtgraves; Patrick McNamara; Kevin Cappaert; Raymond Durso
Journal:  Brain Cogn       Date:  2009-09-13       Impact factor: 2.310

Review 3.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

4.  Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson's disease: a longitudinal analysis.

Authors:  Jared J Tanner; Shellie-Anne Levy; Nadine A Schwab; Loren P Hizel; Peter T Nguyen; Michael S Okun; Catherine C Price
Journal:  Clin Neuropsychol       Date:  2016-11-04       Impact factor: 3.535

5.  The relationship of memory and cognition in Parkinson's disease to lateralisation of motor symptoms.

Authors:  M Riklan; S Stellar; C Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

6.  Is there a specific visuo-spatial impairment in Parkinsonians?

Authors:  S Della Sala; G Di Lorenzo; A Giordano; H Spinnler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

7.  Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study.

Authors:  R Cantello; M Gilli; A Riccio; B Bergamasco
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

8.  Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse.

Authors:  R Cantello; M Aguggia; M Gilli; M Delsedime; I Chiardò Cutin; A Riccio; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

9.  Prognostic implications of the motor symptoms of Parkinson's disease with respect to clinical, computertomographic and psychometric parameters.

Authors:  G Ransmayr; W Poewe; S Plörer; F Gerstenbrand; K Leidlmair; U Mayr
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

10.  Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.

Authors:  A Agniel; P Celsis; G Viallard; J L Montastruc; O Rascol; J F Demonet; J P Marc-Vergnes; A Rascol
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.